Jean-Francois Formela
SlowingNamed in filings at Atlas Venture
- Board seats filed
- 17
all filings on record
Named in filings at Atlas Venture
all filings on record
last 24 months
from a verified or cited source
| Antares Therapeutics | Biotech & pharma | May 2025 | Abingworth Bioventures |
| Ikena Oncology | Biotech & pharma | August 2023 | Orbimed Asia Partners, Orbimed Genesis |
| Amagma | Biotech & pharma | December 2022 | Borealis, Polaris Partners |
| Scorpion Therapeutics | Biotech & pharma | November 2020 | Abingworth Bioventures, Vida Ventures |
| IFM Quattro | Biotech & pharma | November 2019 | Abingworth Bioventures |
| IFM Continua | Biotech & pharma | November 2019 | Abingworth Bioventures |
| IFM Cinque | Biotech & pharma | November 2019 | Abingworth Bioventures |
| KORRO BIO | Biotech & pharma | May 2019 | None on file |
| IFM Tre | Biotech & pharma | July 2018 | Abingworth Bioventures |
| Spero Therapeutics | Biotech & pharma | March 2017 | None on file |
| Translate Bio | Biotech & pharma | December 2016 | None on file |
| IFM Therapeutics | Biotech & pharma | June 2016 | None on file |
| Intellia Therapeutics | Biotech & pharma | August 2015 | Caduceus Capital, Orbimed Asia Partners, Orbimed Genesis |
| Navitor Pharmaceuticals | Biotech & pharma | September 2013 | None on file |
| Annovation BioPharma | Biotech & pharma | July 2012 | Partners Innovation |
| HORIZON PHARMA | Biotech & pharma | February 2012 | None on file |
| ARCA biopharma | Biotech & pharma | December 2011 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Jean-Francois Formela on the board, based on 17 filed seats with a verified or cited source.